A Melbourne-based craft brewery has had its ‘Urban Ale’ trade mark cancelled, with a judge finding other beer makers might want to use the words to describe their products and that cancelling the mark would be in the public interest.
A lawyer for Tasmanian state government owned ports company TasPorts has criticised the ACCC’s first-of-its kind case that alleges it is misusing its market power to stymie competition, saying it isn’t clear what the regulator wants the court to do.
A leading class action and insolvency litigator at Squire Patton Boggs is leaving the firm to launch a boutique outfit with plans to shake up the legal industry, including by bringing class actions on a contingency fee basis.
ANZ has won access to documents the bank claims are crucial to its defence in a high stakes criminal cartel case, but the Australian Securities and Investments Commission has flagged a possible appeal of the ruling.
Television network Channel Seven has been ordered to pay $280,000 in damages to a lawyer after an appeals court ruled a Today Tonight segment labelling her a “Centrelink cheat” was defamatory.
A former director of Atrum Coal has been ordered to pay over $6 million owed to a unit of Hong Kong finance giant Argonaut Group after a prior default saw the former executive lose $12 million worth of shares in the company.
A Gold Coast development property procured through a settlement with a Sydney-based financial advisory firm facing two separate class actions can be sold to recoup losses by investors who sank over $14 million into a property investment scheme, a court has found.
The NSW government has flagged a possible challenge to a class action over Sydney’s $3 billion delayed light rail project as the four-week trial scheduled for June is pushed back another year to allow time for more discovery.
Online real estate giant Domain has filed a lawsuit against an up-and-coming competitor in the property listings market, alleging the startup’s ads misleadingly claim it will have property listings before any of its rivals.
Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company’s ‘Access’ trade mark is likely to confuse consumers.